Cite
HARVARD Citation
Giudice, L. et al. (2022). Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2). Lancet. 399 (10343), pp. 2267-2279. [Online].